Non-selective Kinase Inhibitors

Abstract

Disclosed herein are compounds, compositions, and methods for preventing and treating proliferative diseases associated with aberrant receptor tyrosine kinase (RTK) activity. The therapeutic indications described herein more specifically relate to the non-selective inhibition of RTKs associated with vascular and pulmonary disorders.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 2, 2019
  • Application: Jul 26, 2017
    US US 201715660551 A
  • Priority: Jul 26, 2017
    US US 201715660551 A
  • Priority: Jul 9, 2015
    US US 201514760139 A
  • Priority: Jan 9, 2014
    US US 2014/0010778 W
  • Priority: Oct 11, 2013
    US US 201361889887 P
  • Priority: Jan 10, 2013
    US US 201361751217 P

Download Citation


Sign in to the Lens

Feedback